Literature DB >> 30096300

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.

Antoni Ribas, Reinhard Dummer, Igor Puzanov, Ari VanderWalde, Robert H I Andtbacka, Olivier Michielin, Anthony J Olszanski, Josep Malvehy, Jonathan Cebon, Eugenio Fernandez, John M Kirkwood, Thomas F Gajewski, Lisa Chen, Kevin S Gorski, Abraham A Anderson, Scott J Diede, Michael E Lassman, Jennifer Gansert, F Stephen Hodi, Georgina V Long.   

Abstract

Year:  2018        PMID： 30096300     DOI： 10.1016/j.cell.2018.07.035

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  44 in total

1.  Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC.

Authors:  Yonghui Zhang; Hailin Zhang; Mei Wei; Tao Mou; Tao Shi; Yanyu Ma; Xinyu Cai; Yunzheng Li; Jie Dong; Jiwu Wei
Journal:  Mol Ther       Date:  2019-08-05       Impact factor: 11.454

Review 2.  ImmunoPET: harnessing antibodies for imaging immune cells.

Authors:  Anna M Wu; Neeta Pandit-Taskar
Journal:  Mol Imaging Biol       Date:  2021-09-22       Impact factor: 3.488

3.  High-dose VitC plus oncolytic adenoviruses enhance immunogenic tumor cell death and reprogram tumor immune microenvironment.

Authors:  Jinhu Ma; Chunxue Zhang; Gang Shi; Dan Yue; Yongheng Shu; Shichuan Hu; Zhongbing Qi; Yanwei Chen; Bin Zhang; Yong Zhang; Anliang Huang; Chao Su; Yan Zhang; Hongxin Deng; Ping Cheng
Journal:  Mol Ther       Date:  2021-09-20       Impact factor: 11.454

4.  Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.

Authors:  Catherine S Grasso; Jennifer Tsoi; Mykola Onyshchenko; Gabriel Abril-Rodriguez; Petra Ross-Macdonald; Megan Wind-Rotolo; Ameya Champhekar; Egmidio Medina; Davis Y Torrejon; Daniel Sanghoon Shin; Phuong Tran; Yeon Joo Kim; Cristina Puig-Saus; Katie Campbell; Agustin Vega-Crespo; Michael Quist; Christophe Martignier; Jason J Luke; Jedd D Wolchok; Douglas B Johnson; Bartosz Chmielowski; F Stephen Hodi; Shailender Bhatia; William Sharfman; Walter J Urba; Craig L Slingluff; Adi Diab; John B A G Haanen; Salvador Martin Algarra; Drew M Pardoll; Valsamo Anagnostou; Suzanne L Topalian; Victor E Velculescu; Daniel E Speiser; Anusha Kalbasi; Antoni Ribas
Journal:  Cancer Cell       Date:  2020-09-10       Impact factor: 31.743

Review 5.  Beta-Adrenergic Signaling in Tumor Immunology and Immunotherapy.

Authors:  Wei Wang; Xuefang Cao
Journal:  Crit Rev Immunol       Date:  2019       Impact factor: 2.214

Review 6.  Evolving Role of Oncolytic Virotherapy: Challenges and Prospects in Clinical Practice.

Authors:  Omeed Moaven; Christopher W Mangieri; John A Stauffer; Panos Z Anastasiadis; Mitesh J Borad
Journal:  JCO Precis Oncol       Date:  2021-02-24

Review 7.  Vaccinia virus-based vector against infectious diseases and tumors.

Authors:  Ziling Zhang; Lanlan Dong; Chen Zhao; Peiyong Zheng; Xiaoyan Zhang; Jianqing Xu
Journal:  Hum Vaccin Immunother       Date:  2021-02-19       Impact factor: 3.452

Review 8.  Promises and challenges of adoptive T-cell therapies for solid tumours.

Authors:  Matteo Morotti; Ashwag Albukhari; Abdulkhaliq Alsaadi; Mara Artibani; James D Brenton; Stuart M Curbishley; Tao Dong; Michael L Dustin; Zhiyuan Hu; Nicholas McGranahan; Martin L Miller; Laura Santana-Gonzalez; Leonard W Seymour; Tingyan Shi; Peter Van Loo; Christopher Yau; Helen White; Nina Wietek; David N Church; David C Wedge; Ahmed A Ahmed
Journal:  Br J Cancer       Date:  2021-03-29       Impact factor: 7.640

9.  Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer.

Authors:  Tomoya Kato; Mikihito Nakamori; Shuichi Matsumura; Masaki Nakamura; Toshiyasu Ojima; Hiroshi Fukuhara; Yasushi Ino; Tomoki Todo; Hiroki Yamaue
Journal:  Oncol Lett       Date:  2021-04-23       Impact factor: 2.967

10.  LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells.

Authors:  Suyeon Kim; Hanbyoul Cho; Soon-Oh Hong; Se Jin Oh; Hyo-Jung Lee; Eunho Cho; Seon Rang Woo; Joon Seon Song; Joon-Yong Chung; Sung Wook Son; Sang Min Yoon; Yu-Min Jeon; Seunghyun Jeon; Cassian Yee; Kyung-Mi Lee; Stephen M Hewitt; Jae-Hoon Kim; Kwon-Ho Song; Tae Woo Kim
Journal:  Autophagy       Date:  2020-08-14       Impact factor: 16.016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.